Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MMP1 | P03956 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.41 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.40 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.40 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.40 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.40 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.40 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.40 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.40 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.40 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.40 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.40 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4602951 | 1.00 | NPSR1 (0.48) | NPSR1CCR1MEN1KMT2AMMP1 | |
| SCHEMBL4886049 | 0.92 | KMT2A (0.43) | NPSR1MEN1KMT2ATSHRPOLB | |
| SCHEMBL4886058 | 0.92 | KMT2A (0.43) | NPSR1MEN1KMT2ATSHRPOLB | |
| SCHEMBL14066497 | 0.91 | TSHR (0.44) | NPSR1MEN1KMT2ATSHR | |
| SCHEMBL4602320 | 0.90 | NPSR1 (0.46) | NPSR1CCR1MEN1KMT2AMMP2 | |
| SCHEMBL4602474 | 0.90 | MMP1 (0.44) | NPSR1CCR1MEN1KMT2AMMP1 | |
| SCHEMBL4887987 | 0.89 | TSHR (0.41) | NPSR1MEN1KMT2AMMP1TSHR | |
| SCHEMBL4887977 | 0.89 | TSHR (0.41) | NPSR1MEN1KMT2AMMP1TSHR | |
| SCHEMBL4877176 | 0.84 | MMP2 (0.53) | NPSR1CCR1MEN1KMT2AMMP1 | |
| SCHEMBL4603007 | 0.82 | NPC1 (0.41) | MEN1KMT2AMMP1TSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234333-A1 | Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof | KANG JAE-HOON | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234333-A1 | Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof | PDF, PEPD, DHPS | NPSR1 3773/4885CCR1 4406/4885MEN1 3235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.